Document Detail


Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration.
MedLine Citation:
PMID:  1477228     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Predisposing conditions for acute bacterial meningitis include prematurity, young age, management in an intensive care setting, low socioeconomic background, and crowded living conditions. Clinical findings vary with age and may be nonspecific (altered feeding behavior) or specific (Kernig and Brudzinski signs). Examination and culture of cerebrospinal fluid (CSF) are essential for diagnosis. Antigen identification in CSF, serum, or urine by latex agglutination or other techniques can be useful in the identification of the pathogen. Randomized, controlled studies with a single-, double-, or evaluator-blinded design are encouraged. Among neonates, infants, and children, CSF should be examined again 24-36 hours after initiation of therapy. Outcomes should be judged by both clinical and microbiological criteria. Assessment of microbiological outcome is paramount.
Authors:
G H McCracken; M A Sande; A Lentnek; R J Whitley; W M Scheld
Related Documents :
10589908 - The body louse as a vector of reemerging human diseases.
3763918 - Clinical intravenous urography: comparative trial of ioxaglate and iopamidol.
6726518 - C-reactive protein as a detector of organic complications during recovery from childhoo...
6606008 - Haemophilus influenzae b bacteremia and meningitis in infant rabbits after intranasal i...
21692718 - Congenital cytomegalovirus - time to diagnosis, management and clinical sequelae in aus...
22595378 - The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone c...
Publication Detail:
Type:  Guideline; Journal Article; Practice Guideline; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  15 Suppl 1     ISSN:  1058-4838     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1993-02-05     Completed Date:  1993-02-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S182-8     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of Texas, Southwestern Medical Center, Dallas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Anti-Infective Agents / therapeutic use*
Clinical Protocols / standards
Clinical Trials as Topic / standards*
Clinical Trials, Phase I as Topic / standards
Clinical Trials, Phase II as Topic / standards
Clinical Trials, Phase III as Topic / standards
Humans
Meningitis, Bacterial / drug therapy*
Research Design
Grant Support
ID/Acronym/Agency:
HHS 223-88-1301/HS/AHRQ HHS
Chemical
Reg. No./Substance:
0/Anti-Infective Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of new anti-infective drugs for the treatment of infections of prosthetic hip joints. Inf...
Next Document:  Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Dise...